Prevalence of pertussis antibodies in umbilical cord blood samples in Catalonia, Spain

Pediatric Infectious Disease Journal

Volumn 27, Issue 11, 2008, Pages 1023-1025

  Plans, Pedro ^a,b,d   Jansà, Josep Maria ^a   Doshi, Nita ^c   Harrison, Timothy G ^c   Plasència, Antoni ^a  

^a Department of Health of Catalonia ^*  (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d Health Department of Catalonia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; PERTUSSIS ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PERTUSSIS; PRIORITY JOURNAL; SPAIN; UMBILICAL CORD BLOOD; BLOOD; BORDETELLA PERTUSSIS; CHI SQUARE DISTRIBUTION; FETUS BLOOD; IMMUNOLOGY; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHI-SQUARE DISTRIBUTION; FEMALE; FETAL BLOOD; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SPAIN; WHOOPING COUGH;

EID: 58149173203     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318179264b     Document Type: Article

References (15)

1. Pebody RG, Gay NJ, Giammanco A, et al. The seroepidemiology of Bordetella pertussisin Western Europe. Epidemiol Infect. 2005;133: 159-171.
2. Servicio de Vigilancia Epidemiológica. Comentario epidemiológico de las enfermedades de declaración obligatoria y sistema de information microbiológica. España. Año 2003. Bol Epidemiol Semanal. 2004;12: 101-108.
3. Institut d'Estadística de Catalunya. Anuari Estadístic de Catalunya 2003. Barcelona: Institut d'Estadísitca de Catalunya; 2004.
4. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis. 2004;190:335-340.
5. Gonik B, Puder KS, Gonik N, Kruger M. Seroprevalence of Bordetella pertussisantibodies in mothers and their newborn infants. Infect Dis Obstet Gynecol. 2005;13:59-61.
6. Elliott E, Mclntyre P, Ridley G, et al. National study of infants hospitalised with pertusis in the acellular pertusis vaccine era. Pediatr Infect Dis J. 2005;23:246-252.
7. Schellekens J, Wirsing von Konig C, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J. 2005;24:S19-S24.
8. Office of Population Census and Surveys. Classification of Occupations. London: Office of Population Census; 1980.
9. Giammanco A, Chiarini A, Maple PAC, et al. European Sero-Epidemil-ogy Network: standardisation of the assay resuts for pertussis. Vaccine. 2003;22:112-120.
10. Melker HE, Versteegh FGA, Conyn-van Spaendonck MA, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. JClin Microbiol. 2000;38:800-806.
11. Nardone A, Pebody RG, Maple PAC, Andrews N, Gay NJ, Millar E. Sero-epidemiology of Bordetella pertussis in England and Wales. Vaccine. 2004;22:1314-1319.
12. Healy CM, Rench MA, Edwards KM, Baker CJ. Pertussis serostatus among neonates born to Hispanic women. Clin Infec Dis. 2006;42: 1439-1442.
13. Yeh SH. Pertussis: persistent pathogen, imperfect vaccines. Expert Rev Vaccines. 2003;2:113-127.
14. Van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis. 1990;161:487-492.
15. Belloni C, De Silvestri A, Tinelli C, et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics. 2003;111. 1042-1045.